Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model.
Alport syndrome (AS) is a genetic disorder marked by mutations in type IV collagen, leading to kidney glomerular dysfunction. AS also involves the cochlea, causing late-onset progressive hearing loss. Currently, there are no therapeutic drugs to protect hearing from AS. HDAC inhibitors (HDACis) are...
Saved in:
Main Authors: | Yoon Seok Nam, Eun-Ji Gi, Yoo-Seung Ko, Sungsu Lee, Hyong-Ho Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316033 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Role of Prognostic Factors on Hearing Outcome in Unilateral Idiopathic Sudden Onset Sensorineural Hearing Loss
by: Namrata Yadav, et al.
Published: (2023-09-01) -
Impact of over 6 months of digital hearing aid usage on auditory working memory in acquired severe to profound hearing loss
by: Arun K. Yadav, et al.
Published: (2025-01-01) -
Age of detection of congenital hearing loss in South Africa: A systematic review
by: Mukovhe Phanguphangu, et al.
Published: (2025-01-01) -
Efficacy and fibrinogen correlations of defibrinogen therapy in idiopathic sudden sensorineural hearing loss
by: Bing Wang, et al.
Published: (2025-02-01) -
Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats
by: Riddhi Vichare, et al.
Published: (2025-02-01)